BioSpace News Archive

Press Releases

Novavax Reports First Quarter 2025 Financial Results and Operational Highlights

May 8, 2025
·
18 min read
Press Releases

Adial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug Administration

May 8, 2025
·
4 min read
Press Releases

OM1 to Present Groundbreaking Research on GLP-1 Agonists and Suicidal Ideation at ISPOR 2025

May 8, 2025
·
1 min read
Press Releases

n-Lorem Foundation Identifies New, Important Roles of JIP3, Offering Critical Insights into Therapeutic Approaches for Nano-rare Patients

May 8, 2025
·
5 min read
Press Releases

Yamo Pharma Presents Statistically Significant Phase 2 Autism Results for L1-79 at INSAR 2025

Trial achieves unprecedented and clinically meaningful socialization gains in adolescents and young adults, addressing core autism symptoms currently lacking FDA-approved therapies.

May 8, 2025
·
1 min read
Press Releases

Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy

1,000 GMP doses of MDMA now reaching patients with PTSD under Australia’s Authorised Prescriber Scheme; Department of Veterans’ Affairs to fund treatment for veterans

May 8, 2025
·
5 min read
Press Releases

Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin

May 8, 2025
·
3 min read
Press Releases

TransMedics Reports First Quarter 2025 Financial Results

May 8, 2025
·
10 min read
Press Releases

Spyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 8, 2025
·
15 min read
Press Releases

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

May 8, 2025
·
6 min read